http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 11 Sep 2026 18:12:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Sep+10++Filed+by%3A+Hochman+David+P/27053840.html si-local-file:///var/storage/secattach/20260911/27053840.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Sep+10++Filed+by%3A+Hochman+David+P/27053840.html Fri, 11 Sep 2026 18:12:00 -0400 OBIO http://www.streetinsider.com/Hot+Upgrades/BTIG+Upgrades+Orchestra+BioMed+Inc.+%28OBIO%29+to+Buy/27044372.html (Updated - September 10, 2026 5:32 AM EDT) <p>BTIG analyst Marie Thibault upgraded Orchestra BioMed Inc. (NASDAQ: OBIO) from Neutral to Buy with a price target of $10.00.</p><p>The analyst comments "We are upgrading our recommendation on Orchestra BioMed from Neutral to Buy and setting a $10 PT. We have become more constructive on the stock following recent management commentary detailing that the BACKBEAT trial is set to finish enrollment on schedule around the end of Q3. We had previously felt that hitting timelines, securing non-dilutive financing, and establishing a near-term catalyst pathway were the key criteria for an upgrade. OBIO has http://www.streetinsider.com/Hot+Upgrades/BTIG+Upgrades+Orchestra+BioMed+Inc.+%28OBIO%29+to+Buy/27044372.html Thu, 10 Sep 2026 05:32:47 -0400 OBIO http://www.streetinsider.com/Upgrades/BTIG+Upgrades+Orchestra+BioMed+Inc.+%28OBIO%29+to+Buy/27044372.html (Updated - September 10, 2026 5:32 AM EDT) <p>BTIG analyst Marie Thibault upgraded Orchestra BioMed Inc. (NASDAQ: OBIO) from Neutral to Buy with a price target of $10.00.</p><p>The analyst comments "We are upgrading our recommendation on Orchestra BioMed from Neutral to Buy and setting a $10 PT. We have become more constructive on the stock following recent management commentary detailing that the BACKBEAT trial is set to finish enrollment on schedule around the end of Q3. We had previously felt that hitting timelines, securing non-dilutive financing, and establishing a near-term catalyst pathway were the key criteria for an upgrade. OBIO has http://www.streetinsider.com/Upgrades/BTIG+Upgrades+Orchestra+BioMed+Inc.+%28OBIO%29+to+Buy/27044372.html Thu, 10 Sep 2026 05:32:47 -0400 OBIO http://www.streetinsider.com/Analyst+Comments/BTIG+Upgrades+Orchestra+BioMed+Inc.+%28OBIO%29+to+Buy/27044372.html (Updated - September 10, 2026 5:32 AM EDT) <p>BTIG analyst Marie Thibault upgraded Orchestra BioMed Inc. (NASDAQ: OBIO) from Neutral to Buy with a price target of $10.00.</p><p>The analyst comments "We are upgrading our recommendation on Orchestra BioMed from Neutral to Buy and setting a $10 PT. We have become more constructive on the stock following recent management commentary detailing that the BACKBEAT trial is set to finish enrollment on schedule around the end of Q3. We had previously felt that hitting timelines, securing non-dilutive financing, and establishing a near-term catalyst pathway were the key criteria for an upgrade. OBIO has http://www.streetinsider.com/Analyst+Comments/BTIG+Upgrades+Orchestra+BioMed+Inc.+%28OBIO%29+to+Buy/27044372.html Thu, 10 Sep 2026 05:32:47 -0400 OBIO http://www.streetinsider.com/Hot+Comments/BTIG+Upgrades+Orchestra+BioMed+Inc.+%28OBIO%29+to+Buy/27044372.html (Updated - September 10, 2026 5:32 AM EDT) <p>BTIG analyst Marie Thibault upgraded Orchestra BioMed Inc. (NASDAQ: OBIO) from Neutral to Buy with a price target of $10.00.</p><p>The analyst comments "We are upgrading our recommendation on Orchestra BioMed from Neutral to Buy and setting a $10 PT. We have become more constructive on the stock following recent management commentary detailing that the BACKBEAT trial is set to finish enrollment on schedule around the end of Q3. We had previously felt that hitting timelines, securing non-dilutive financing, and establishing a near-term catalyst pathway were the key criteria for an upgrade. OBIO has http://www.streetinsider.com/Hot+Comments/BTIG+Upgrades+Orchestra+BioMed+Inc.+%28OBIO%29+to+Buy/27044372.html Thu, 10 Sep 2026 05:32:47 -0400 OBIO http://www.streetinsider.com/Press+Releases/Orchestra+BioMed+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/27018870.html <p align="justify">NEW HOPE, Pa., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, reported today that, on September 1, 2026, the Compensation Committee of the Orchestra BioMed Board of Directors granted stock options to purchase an aggregate of 133,000 shares of the Company’s common stock to seven newly hired employees. The awards were granted pursuant to the Orchestra Biomed Holdings, Inc. 2025 New Hire Inducement Plan as an inducement material to each new http://www.streetinsider.com/Press+Releases/Orchestra+BioMed+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/27018870.html Wed, 02 Sep 2026 16:05:00 -0400 OBIO http://www.streetinsider.com/Globe+Newswire/Orchestra+BioMed+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/27018870.html <p align="justify">NEW HOPE, Pa., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, reported today that, on September 1, 2026, the Compensation Committee of the Orchestra BioMed Board of Directors granted stock options to purchase an aggregate of 133,000 shares of the Company’s common stock to seven newly hired employees. The awards were granted pursuant to the Orchestra Biomed Holdings, Inc. 2025 New Hire Inducement Plan as an inducement material to each new http://www.streetinsider.com/Globe+Newswire/Orchestra+BioMed+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/27018870.html Wed, 02 Sep 2026 16:05:00 -0400 OBIO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+26++Filed+by%3A+Taylor+Andrew+Lawrence/26998160.html si-local-file:///var/storage/secattach/20260828/26998160.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+26++Filed+by%3A+Taylor+Andrew+Lawrence/26998160.html Fri, 28 Aug 2026 16:17:00 -0400 O.49531689 OBIO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+26++Filed+by%3A+Taylor+Andrew+Lawrence/26998160.html si-local-file:///var/storage/secattach/20260828/26998160.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+26++Filed+by%3A+Taylor+Andrew+Lawrence/26998160.html Fri, 28 Aug 2026 16:17:00 -0400 O.49531689 OBIO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+26++Filed+by%3A+Sherman+Darren/26998111.html si-local-file:///var/storage/secattach/20260828/26998111.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+26++Filed+by%3A+Sherman+Darren/26998111.html Fri, 28 Aug 2026 16:16:00 -0400 O.49531689 OBIO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+26++Filed+by%3A+Sherman+Darren/26998111.html si-local-file:///var/storage/secattach/20260828/26998111.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+26++Filed+by%3A+Sherman+Darren/26998111.html Fri, 28 Aug 2026 16:16:00 -0400 O.49531689 OBIO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+26++Filed+by%3A+Aiello+Joshua/26998071.html si-local-file:///var/storage/secattach/20260828/26998071.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+26++Filed+by%3A+Aiello+Joshua/26998071.html Fri, 28 Aug 2026 16:15:00 -0400 O.49531689 OBIO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+26++Filed+by%3A+Aiello+Joshua/26998071.html si-local-file:///var/storage/secattach/20260828/26998071.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+26++Filed+by%3A+Aiello+Joshua/26998071.html Fri, 28 Aug 2026 16:15:00 -0400 O.49531689 OBIO http://www.streetinsider.com/Press+Releases/Orchestra+BioMed+to+Participate+in+the+H.C.+Wainwright+28th+Annual+Global+Investment+Conference/26985440.html <p align="justify">NEW HOPE, Pa., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that Chairman and CEO David Hochman will present at the H.C. Wainwright 28th Annual Global Investment Conference on Wednesday, Sept. 16, 2026 at 9:00am ET, and will also host one-on-one meetings with investors that day.</p> <p align="justify"><strong>About Orchestra BioMed</strong><br/>Orchestra BioMed is a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations with market-leading global medical device companies. The http://www.streetinsider.com/Press+Releases/Orchestra+BioMed+to+Participate+in+the+H.C.+Wainwright+28th+Annual+Global+Investment+Conference/26985440.html Thu, 27 Aug 2026 08:30:00 -0400 O.49531689 OBIO http://www.streetinsider.com/Press+Releases/Orchestra+BioMed+to+Participate+in+the+H.C.+Wainwright+28th+Annual+Global+Investment+Conference/26985440.html <p align="justify">NEW HOPE, Pa., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that Chairman and CEO David Hochman will present at the H.C. Wainwright 28th Annual Global Investment Conference on Wednesday, Sept. 16, 2026 at 9:00am ET, and will also host one-on-one meetings with investors that day.</p> <p align="justify"><strong>About Orchestra BioMed</strong><br/>Orchestra BioMed is a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations with market-leading global medical device companies. The http://www.streetinsider.com/Press+Releases/Orchestra+BioMed+to+Participate+in+the+H.C.+Wainwright+28th+Annual+Global+Investment+Conference/26985440.html Thu, 27 Aug 2026 08:30:00 -0400 O.49531689 OBIO http://www.streetinsider.com/Globe+Newswire/Orchestra+BioMed+to+Participate+in+the+H.C.+Wainwright+28th+Annual+Global+Investment+Conference/26985440.html <p align="justify">NEW HOPE, Pa., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that Chairman and CEO David Hochman will present at the H.C. Wainwright 28th Annual Global Investment Conference on Wednesday, Sept. 16, 2026 at 9:00am ET, and will also host one-on-one meetings with investors that day.</p> <p align="justify"><strong>About Orchestra BioMed</strong><br/>Orchestra BioMed is a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations with market-leading global medical device companies. The http://www.streetinsider.com/Globe+Newswire/Orchestra+BioMed+to+Participate+in+the+H.C.+Wainwright+28th+Annual+Global+Investment+Conference/26985440.html Thu, 27 Aug 2026 08:30:00 -0400 O.49531689 OBIO http://www.streetinsider.com/Globe+Newswire/Orchestra+BioMed+to+Participate+in+the+H.C.+Wainwright+28th+Annual+Global+Investment+Conference/26985440.html <p align="justify">NEW HOPE, Pa., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that Chairman and CEO David Hochman will present at the H.C. Wainwright 28th Annual Global Investment Conference on Wednesday, Sept. 16, 2026 at 9:00am ET, and will also host one-on-one meetings with investors that day.</p> <p align="justify"><strong>About Orchestra BioMed</strong><br/>Orchestra BioMed is a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations with market-leading global medical device companies. The http://www.streetinsider.com/Globe+Newswire/Orchestra+BioMed+to+Participate+in+the+H.C.+Wainwright+28th+Annual+Global+Investment+Conference/26985440.html Thu, 27 Aug 2026 08:30:00 -0400 O.49531689 OBIO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+12++Filed+by%3A+Pacitti+David/26931086.html si-local-file:///var/storage/secattach/20260814/26931086.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+12++Filed+by%3A+Pacitti+David/26931086.html Fri, 14 Aug 2026 16:25:00 -0400 O.49531689 OBIO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+12++Filed+by%3A+Pacitti+David/26931086.html si-local-file:///var/storage/secattach/20260814/26931086.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+12++Filed+by%3A+Pacitti+David/26931086.html Fri, 14 Aug 2026 16:25:00 -0400 O.49531689 OBIO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+12++Filed+by%3A+Fain+Eric+S/26931060.html si-local-file:///var/storage/secattach/20260814/26931060.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+12++Filed+by%3A+Fain+Eric+S/26931060.html Fri, 14 Aug 2026 16:24:00 -0400 O.49531689 OBIO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+12++Filed+by%3A+Fain+Eric+S/26931060.html si-local-file:///var/storage/secattach/20260814/26931060.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+12++Filed+by%3A+Fain+Eric+S/26931060.html Fri, 14 Aug 2026 16:24:00 -0400 O.49531689 OBIO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+12++Filed+by%3A+Mack+John+Prosper/26930950.html si-local-file:///var/storage/secattach/20260814/26930950.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+12++Filed+by%3A+Mack+John+Prosper/26930950.html Fri, 14 Aug 2026 16:23:00 -0400 O.49531689 OBIO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+12++Filed+by%3A+Mack+John+Prosper/26930950.html si-local-file:///var/storage/secattach/20260814/26930950.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+12++Filed+by%3A+Mack+John+Prosper/26930950.html Fri, 14 Aug 2026 16:23:00 -0400 O.49531689 OBIO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+12++Filed+by%3A+Cleary+Chris/26930909.html si-local-file:///var/storage/secattach/20260814/26930909.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+12++Filed+by%3A+Cleary+Chris/26930909.html Fri, 14 Aug 2026 16:22:00 -0400 O.49531689 OBIO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+12++Filed+by%3A+Cleary+Chris/26930909.html si-local-file:///var/storage/secattach/20260814/26930909.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orchestra+BioMed+Holding++For%3A+Aug+12++Filed+by%3A+Cleary+Chris/26930909.html Fri, 14 Aug 2026 16:22:00 -0400 O.49531689 OBIO